DCNL1 Functions As a Substrate Sensor and Activator of Cullin 2-RING Ligase

Total Page:16

File Type:pdf, Size:1020Kb

DCNL1 Functions As a Substrate Sensor and Activator of Cullin 2-RING Ligase DCNL1 Functions as a Substrate Sensor and Activator of Cullin 2-RING Ligase Pardeep Heir, Roxana I. Sufan, Samantha N. Greer, Betty P. Poon, Jeffrey E. Lee, Michael Ohh Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada Downloaded from Substrate engagement by F-box proteins promotes NEDD8 modification of cullins, which is necessary for the activation of cul- lin-RING E3 ubiquitin ligases (CRLs). However, the mechanism by which substrate recruitment triggers cullin neddylation re- mains unclear. Here, we identify DCNL1 (defective in cullin neddylation 1-like 1) as a component of CRL2 called ECV (elongins BC/CUL2/VHL) and show that molecular suppression of DCNL1 attenuates CUL2 neddylation. DCNL1 via its DAD patch binds to CUL2 but is also able to bind VHL independent of CUL2 and the DAD patch. The engagement of the substrate hypoxia-induc- ible factor 1␣ (HIF1␣) to the substrate receptor VHL increases DCNL1 binding to VHL as well as to CUL2. Notably, an engi- neered mutant form of HIF1␣ that associates with CUL2, but not DCNL1, fails to trigger CUL2 neddylation and retains ECV in an inactive state. These findings support a model in which substrate engagement prompts DCNL1 recruitment that facilitates the initiation of CUL2 neddylation and define DCNL1 as a “substrate sensor switch” for ECV activation. http://mcb.asm.org/ ullin-RING ligases (CRLs), the largest family of E3 ubiquitin A235, and D241 in DCNL1), and it can also bind Ubc12 (12). It Cligases, are multiprotein complexes involved in protein deg- has been proposed that it is the concerted action of Dcn1 and Rbx1 radation (1, 2). They are assembled on a cullin scaffold (CUL1, that promotes cullin neddylation (14). However, the molecular CUL2, CUL3, CUL4A, CUL4B, and CUL5) and contain a RING events responsible for recruiting DCNL1 to cullin scaffolds for finger protein (RBX1 or RBX2) at the cullin C-terminal domain neddylation have remained unclear. (CTD) as well as a substrate receptor, which generally associates von Hippel-Lindau tumor suppressor protein (VHL) is the with the cullin N-terminal domain (NTD) via adaptor proteins substrate receptor of the CUL2-based CRL called ECV (elongins on December 14, 2020 at UNIV OF TORONTO (2). CUL3-based CRLs are the exception in which the Broad com- BC/CUL2/VHL) (15). VHL contains an ␣ domain, which binds plex, Tramtrack, and Bric-a-Brac (BTB)-domain containing pro- the elongin C adaptor protein that is critical for bridging VHL to tein mediates both substrate specificity and binding to CUL3 CUL2, and a ␤ domain, which recognizes substrates that have without the need of adaptor proteins (3). been posttranslationally modified for subsequent ubiquitylation The process of attaching ubiquitin onto a CRL substrate re- (16, 17). Hypoxia-inducible factor ␣ (HIF␣), the best-character- quires three enzymes. Using ATP, an E1 activating enzyme forms ized substrate of ECV, is targeted for polyubiquitylation upon a thioester bond between its catalytic cysteine residue and the hydroxylation of conserved proline residues within the oxygen- C-terminal carboxyl group of ubiquitin (4). The activated ubiqui- dependent degradation (ODD) domain, which is catalyzed by tin is then transferred onto the catalytic cysteine of an E2 conju- prolyl-hydroxylase enzymes in the presence of oxygen (18–21). gating enzyme (4). CRL through RBX1/2 helps transfer ubiquitin Under reduced oxygen tension or hypoxia, HIF␣ remains unhy- from E2 onto a lysine residue on the bound substrate (2). Neddy- droxylated, escapes ECV-dependent degradation, and het- lation, the process of conjugating the ubiquitin-like protein erodimerizes with HIF␤ to form an active transcription factor for NEDD8 onto a substrate, follows an analogous cascade (5, 6). the transactivation of numerous genes containing hypoxia-re- Cullins are modified by NEDD8 (7). Structural studies involving sponsive elements (HREs) to trigger various adaptive responses to CTD CTD the CTD of CUL5 (CUL5 )-RBX1 and NEDD8ϳCUL5 - hypoxia, including glycolysis, erythropoiesis, and angiogenesis RBX1 have demonstrated that in an unneddylated state, RBX1 has (22). Notably, mutations in VHL cause VHL disease, which is limited movement due to inhibitory cullin subdomains, thus re- commonly characterized by the stabilization of HIF␣, overexpres- straining its ability to recruit ubiquitin-charged E2 (8). Neddyla- sion of hypoxia-inducible genes, and the development of multiple tion causes a conformational change in cullin structure that re- tumors in several organ systems such as the central nervous system leases RBX1 from a confined configuration to enhance the binding and the kidney (23). of ubiquitin-charged E2 and thus CRL ubiquitylation capability Engagement of various substrates to their respective CRLs, in- (8, 9). The molecular events involved in the process of neddylation of cullins are not as straightforward as the resulting effects. For CUL1 Received 4 October 2012 Returned for modification 30 October 2012 neddylation to take place, rotation of the RING domain of RBX1 is Accepted 4 February 2013 needed in order to bring the catalytic Cys111 of UBC12 (NEDD8 Published ahead of print 11 February 2013 E2 enzyme) in close proximity to CUL1 Lys720, the NEDD8 ac- Address correspondence to Michael Ohh, [email protected]. ceptor site (10). Defective in cullin neddylation 1 (Dcn1) in Sac- Supplemental material for this article may be found at http://dx.doi.org/10.1128 charomyces cerevisiae (DCNL1 is the human homolog; also known /MCB.01342-12. as SCCRO or DCUN1D1) has been reported to act as an E3 Copyright © 2013, American Society for Microbiology. All Rights Reserved. NEDD8 ligase of cullins (11–13). Dcn1 is able to bind Cdc53 doi:10.1128/MCB.01342-12 (CUL1 homolog) through its DAD patch (amino acids D211, April 2013 Volume 33 Number 8 Molecular and Cellular Biology p. 1621–1631 mcb.asm.org 1621 Heir et al. cluding HIF␣ to ECV, has been shown to induce the neddylation by GenScript and inserted into pcDNA3 using HindIII and BamHI. Con- of cullins, a phenomenon referred to as “substrate-mediated ned- structs that were cloned are described in Table S1 in the supplemental dylation” (24–30). Although the precise molecular mechanism by material. which substrate engagement triggers cullin neddylation and Immunoprecipitation and immunoblotting. Cells were harvested in thereby E3 enzymatic activity remains largely unknown, substrate EBC lysis buffer (50 mM Tris, pH 8, 120 mM NaCl, 0.5% NP-40) and receptors would be predicted to play an important, perhaps criti- supplemented with protease inhibitors (Roche) and MG132 (Peptides International) where indicated in the figure legends. Lysates were immu- cal, role in the substrate-induced CRL activation event, consider- noprecipitated using the indicated antibodies along with protein A-Sep- ing that the substrate receptors serve as the bridge connecting harose (Repligen). Bound proteins were washed five times in NETN buf- substrates to cullins. In this regard, components of the ECV com- fer (20 mM Tris, pH 8, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40), eluted Downloaded from plex, namely, the VHL/elongins BC (VBC) subcomplex, have by boiling in sample buffer, and resolved by SDS-PAGE. Proteins were been crystallized in the presence and absence of a prolyl-hydroxy- electrotransferred onto polyvinylidene difluoride (PVDF) membrane lated HIF1␣ peptide (17, 31, 32). However, the addition of prolyl- (Bio-Rad), blocked, and probed with the antibodies indicated on the fig- hydroxylated HIF1␣ peptide did not cause an appreciable change ures. to the structure of VBC, leaving the mechanism of substrate-me- Luciferase assay. Cells were transfected in triplicate with pGL3- diated neddylation a mystery. 5ϫHRE-Luc (where Luc is luciferase) (kind gift from Richard P. Hill) and Here, we show that DCNL1 is a “substrate sensor switch” pRL-SV40 (where SV40 is simian virus 40) (Promega) Renilla luciferase ␮ whose incorporation into the ECV complex increases upon the control. Cells were treated with 10 M MG132 for4htohelp stabilize ␣ endogenous HIF1␣ in normoxia and lysed at 48 h posttransfection. A recognition of HIF1 by VHL and activates the E3 activity via http://mcb.asm.org/ dual-luciferase reporter assay system (Promega) was used, and lumines- promoting CUL2 neddylation. cence was measured using a Mithras LB940 plate reader (Berthold Tech- MATERIALS AND METHODS nologies). Relative light units (RLU) from firefly luciferase were normal- ized against Renilla luciferase values. Values were standardized against the Cells. 786-O, HEK293A, HEK293T, PC3, and U2OS cells (American Type value for the pGIPZ control cell line, which was arbitrarily set to 100. Culture Collection) were maintained in Dulbecco’s modified Eagle’s me- Lentiviral production and generation of stable shRNA knockdown dium supplemented with 10% heat-inactivated fetal bovine serum cell lines. The following shRNA constructs were obtained from Thermo (Wisent) at 37°C in a humidified atmosphere with 5% CO . TF-1 cells 2 Scientific: pGIPZ (catalog number RHS4346), shRNA targeting DCNL1 (American Type Culture Collection) were maintained in RPMI 1640 me- clone 1 (shDCNL1-1; V3LHS_371768), shDCNL1 clone 2 (shDCNL1-2; dium supplemented with 10% heat-inactivated fetal bovine serum V3LHS_371770), shDCNL3 (V3LHS_360875), and shVHL (V2LHS_ (Wisent) and 2 ng/ml granulocyte-macrophage colony-stimulating factor on December 14, 2020 at UNIV OF TORONTO 202399). HEK293T cells were transfected with psPAX2, pMDG1.vsvg (GM-CSF; Invitrogen). HEK293A and U2OS cells stably expressing short (kind gifts from Linda Z. Penn), and shRNA-containing plasmid. Lenti- hairpin RNA (shRNA) were maintained in 2 ␮g/ml puromycin. virus containing supernatant was collected at 48 and 72 h posttransfection Antibodies and reagents. The following antibodies were obtained and was used for infection after being filtered. HEK293A and U2OS cells from Cell Signaling Technology: glutathione S-transferase (GST; catalog number 2622), hemagglutinin (HA) (mouse, 2367; rabbit, 3724), VHL were selected in puromycin 24 h after infection. Protein purification. pGEX-4T-1-DCNL1 was expressed in (2738), and NEDD8 (2745).
Recommended publications
  • Neddylation: a Novel Modulator of the Tumor Microenvironment Lisha Zhou1,2*†, Yanyu Jiang3†, Qin Luo1, Lihui Li1 and Lijun Jia1*
    Zhou et al. Molecular Cancer (2019) 18:77 https://doi.org/10.1186/s12943-019-0979-1 REVIEW Open Access Neddylation: a novel modulator of the tumor microenvironment Lisha Zhou1,2*†, Yanyu Jiang3†, Qin Luo1, Lihui Li1 and Lijun Jia1* Abstract Neddylation, a post-translational modification that adds an ubiquitin-like protein NEDD8 to substrate proteins, modulates many important biological processes, including tumorigenesis. The process of protein neddylation is overactivated in multiple human cancers, providing a sound rationale for its targeting as an attractive anticancer therapeutic strategy, as evidence by the development of NEDD8-activating enzyme (NAE) inhibitor MLN4924 (also known as pevonedistat). Neddylation inhibition by MLN4924 exerts significantly anticancer effects mainly by triggering cell apoptosis, senescence and autophagy. Recently, intensive evidences reveal that inhibition of neddylation pathway, in addition to acting on tumor cells, also influences the functions of multiple important components of the tumor microenvironment (TME), including immune cells, cancer-associated fibroblasts (CAFs), cancer-associated endothelial cells (CAEs) and some factors, all of which are crucial for tumorigenesis. Here, we briefly summarize the latest progresses in this field to clarify the roles of neddylation in the TME, thus highlighting the overall anticancer efficacy of neddylaton inhibition. Keywords: Neddylation, Tumor microenvironment, Tumor-derived factors, Cancer-associated fibroblasts, Cancer- associated endothelial cells, Immune cells Introduction Overall, binding of NEDD8 molecules to target proteins Neddylation is a reversible covalent conjugation of an can affect their stability, subcellular localization, conform- ubiquitin-like molecule NEDD8 (neuronal precursor ation and function [4]. The best-characterized substrates cell-expressed developmentally down-regulated protein of neddylation are the cullin subunits of Cullin-RING li- 8) to a lysine residue of the substrate protein [1, 2].
    [Show full text]
  • Dynamic Interplay Between Locus-Specific DNA Methylation and Hydroxymethylation Regulates Distinct Biological Pathways in Prostate Carcinogenesis Shivani N
    Kamdar et al. Clinical Epigenetics (2016) 8:32 DOI 10.1186/s13148-016-0195-4 RESEARCH Open Access Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis Shivani N. Kamdar1,2, Linh T. Ho1, Ken J. Kron1, Ruth Isserlin3, Theodorus van der Kwast1,4, Alexandre R. Zlotta5, Neil E. Fleshner6, Gary Bader3 and Bharati Bapat1,2* Abstract Background: Despite the significant global loss of DNA hydroxymethylation marks in prostate cancer tissues, the locus-specific role of hydroxymethylation in prostate tumorigenesis is unknown. We characterized hydroxymethylation and methylation marks by performing whole-genome next-generation sequencing in representative normal and prostate cancer-derived cell lines in order to determine functional pathways and key genes regulated by these epigenomic modifications in cancer. Results: Our cell line model shows disruption of hydroxymethylation distribution in cancer, with global loss and highly specific gain in promoter and CpG island regions. Significantly, we observed locus-specific retention of hydroxymethylation marks in specific intronic and intergenic regions which may play a novel role in the regulation of gene expression in critical functional pathways, such as BARD1 signaling and steroid hormone receptor signaling in cancer. We confirm a modest correlation of hydroxymethylation with expression in intragenic regions in prostate cancer, while identifying an original role for intergenic hydroxymethylation in differentially expressed regulatory pathways in cancer. We also demonstrate a successful strategy for the identification and validation of key candidate genes from differentially regulated biological pathways in prostate cancer. Conclusions: Our results indicate a distinct function for aberrant hydroxymethylation within each genomic feature in cancer, suggesting a specific and complex role for the deregulation of hydroxymethylation in tumorigenesis, similar to methylation.
    [Show full text]
  • DDB1 Functions As a Linker to Recruit Receptor WD40 Proteins to CUL4− ROC1 Ubiquitin Ligases
    Downloaded from genesdev.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH COMMUNICATION domain to bind with a conserved protein motif, the F DDB1 functions as a linker box, which, via its additional protein–protein interaction to recruit receptor WD40 modules, recruits various substrates, often phosphory- lated, to the CUL1–ROC1 catalytic core. To bring spe- proteins to CUL4–ROC1 cific substrates to CUL2- and CUL5-dependent ligases, a ubiquitin ligases heterodimeric linker complex containing elongins B and C binds simultaneously to an analogous N-terminal do- Yizhou Joseph He, Chad M. McCall, Jian Hu, main in CUL2 and CUL5 and to two similar protein 1 motifs, the VHL box and SOCS box. VHL and SOCS pro- Yaxue Zeng, and Yue Xiong teins, via their additional protein–protein interaction Lineberger Comprehensive Cancer Center, Department of modules, target various substrates differentially to the Biochemistry and Biophysics, Program in Molecular Biology CUL2–ROC1 or CUL5–ROC2 catalytic cores (Kamura et and Biotechnology, University of North Carolina, Chapel Hill, al. 1998, 2001, 2004; Stebbins et al. 1999; Zhang et al. North Carolina 27599, USA 1999). Omitting a linker, CUL3 utilizes its N-terminal domain to bind to proteins with a conserved 100-residue Cullins assemble the largest family of ubiquitin ligases protein motif known as a BTB domain, which, via addi- by binding with ROC1 and various substrate receptors. tional protein–protein interaction domains, then target CUL4 function is linked with many cellular processes, various substrates to the CUL3–ROC1 catalytic core (Fu- rukawa et al. 2003; Geyer et al.
    [Show full text]
  • Expression and Purification of Functional Recombinant CUL2
    www.nature.com/scientificreports OPEN Expression and purifcation of functional recombinant CUL2•RBX1 from E. coli Stephanie Diaz1, Lihong Li1,2, Kankan Wang1 & Xing Liu1,2* Cullin-2 (CUL2) based cullin-RING ligases (CRL2s) comprise a family of ubiquitin E3 ligases that exist only in multi-cellular organisms and are crucial for cellular processes such as embryogenesis and viral pathogenesis. CUL2 is the scafold protein that binds one of the interchangeable substrate receptor modules, which consists of adaptor proteins and the substrate receptor protein. The VHL protein is a substrate receptor known to target hypoxia-inducible factor α (HIF1α) for ubiquitination and degradation. Because of its critical role in the ubiquitination of important cellular factors such as HIF1α, CRL2s have been investigated for their biological functions and the development of novel therapeutics against diseases. Given the importance of CRL2s in biological and biomedical research, methods that efciently produce functional CUL2 proteins will greatly facilitate studies on the mechanism and regulation of CRL2s. Here, we report two cost-efective systems for the expression and purifcation of recombinant human CUL2 from E. coli cells. The purifed CUL2 proteins were ~ 95% pure, could bind their substrate receptor modules, and were enzymatically active in transferring ubiquitin or ubiquitin-like protein to the corresponding substrate in in vitro assays. The presented methodological advancements will help advance research in CRL2 function and regulation. Protein turnover is a cellular regulatory system defned by the continuous synthesis and decomposition of specifc proteins to maintain the integrity of optimally functioning proteins 1,2. Abnormalities during protein turnover, specifcally during protein degradation, ofen result in human diseases such as cystic fbrosis and liposarcoma.
    [Show full text]
  • Molecular Signatures Differentiate Immune States in Type 1 Diabetes Families
    Page 1 of 65 Diabetes Molecular signatures differentiate immune states in Type 1 diabetes families Yi-Guang Chen1, Susanne M. Cabrera1, Shuang Jia1, Mary L. Kaldunski1, Joanna Kramer1, Sami Cheong2, Rhonda Geoffrey1, Mark F. Roethle1, Jeffrey E. Woodliff3, Carla J. Greenbaum4, Xujing Wang5, and Martin J. Hessner1 1The Max McGee National Research Center for Juvenile Diabetes, Children's Research Institute of Children's Hospital of Wisconsin, and Department of Pediatrics at the Medical College of Wisconsin Milwaukee, WI 53226, USA. 2The Department of Mathematical Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA. 3Flow Cytometry & Cell Separation Facility, Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907, USA. 4Diabetes Research Program, Benaroya Research Institute, Seattle, WA, 98101, USA. 5Systems Biology Center, the National Heart, Lung, and Blood Institute, the National Institutes of Health, Bethesda, MD 20824, USA. Corresponding author: Martin J. Hessner, Ph.D., The Department of Pediatrics, The Medical College of Wisconsin, Milwaukee, WI 53226, USA Tel: 011-1-414-955-4496; Fax: 011-1-414-955-6663; E-mail: [email protected]. Running title: Innate Inflammation in T1D Families Word count: 3999 Number of Tables: 1 Number of Figures: 7 1 For Peer Review Only Diabetes Publish Ahead of Print, published online April 23, 2014 Diabetes Page 2 of 65 ABSTRACT Mechanisms associated with Type 1 diabetes (T1D) development remain incompletely defined. Employing a sensitive array-based bioassay where patient plasma is used to induce transcriptional responses in healthy leukocytes, we previously reported disease-specific, partially IL-1 dependent, signatures associated with pre and recent onset (RO) T1D relative to unrelated healthy controls (uHC).
    [Show full text]
  • The Structure and Regulation of Cullin 2 Based E3 Ubiquitin Ligases and Their Biological Functions Weijia Cai* and Haifeng Yang*
    Cai and Yang Cell Div (2016) 11:7 DOI 10.1186/s13008-016-0020-7 Cell Division REVIEW Open Access The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions Weijia Cai* and Haifeng Yang* Abstract Background: Cullin-RING E3 ubiquitin ligase complexes play a central role in targeting cellular proteins for ubiquit- ination-dependent protein turnover through 26S proteasome. Cullin-2 is a member of the Cullin family, and it serves as a scaffold protein for Elongin B and C, Rbx1 and various substrate recognition receptors to form E3 ubiquitin ligases. Main body of the abstract: First, the composition, structure and the regulation of Cullin-2 based E3 ubiquitin ligases were introduced. Then the targets, the biological functions of complexes that use VHL, Lrr-1, Fem1b, Prame, Zyg-11, BAF250, Rack1 as substrate targeting subunits were described, and their involvement in diseases was discussed. A small molecule inhibitor of Cullins as a potential anti-cancer drug was introduced. Furthermore, proteins with VHL box that might bind to Cullin-2 were described. Finally, how different viral proteins form E3 ubiquitin ligase complexes with Cullin-2 to counter host viral defense were explained. Conclusions: Cullin-2 based E3 ubiquitin ligases, using many different substrate recognition receptors, recognize a number of substrates and regulate their protein stability. These complexes play critical roles in biological processes and diseases such as cancer, germline differentiation and viral defense. Through the better understanding of their biology, we can devise and develop new therapeutic strategies to treat cancers, inherited diseases and viral infections.
    [Show full text]
  • Mouse Dcun1d1 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Dcun1d1 Knockout Project (CRISPR/Cas9) Objective: To create a Dcun1d1 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Dcun1d1 gene (NCBI Reference Sequence: NM_001205361 ; Ensembl: ENSMUSG00000027708 ) is located on Mouse chromosome 3. 7 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 7 (Transcript: ENSMUST00000108182). Exon 2~4 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a knock-out allele are runted with spleen and lymphoid hypoplasia and decreased mouse embryonic fibroblast proliferation. Males are infertile and exhibit abnormal spermiogenesis. Exon 2 starts from about 0.51% of the coding region. Exon 2~4 covers 66.54% of the coding region. The size of effective KO region: ~4968 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 7 Legends Exon of mouse Dcun1d1 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis.
    [Show full text]
  • Anti-DCUN1D1 Antibody (ARG65153)
    Product datasheet [email protected] ARG65153 Package: 100 μg anti-DCUN1D1 antibody Store at: -20°C Summary Product Description Goat Polyclonal antibody recognizes DCUN1D1 Tested Reactivity Hu Predict Reactivity Ms, Cow Tested Application IHC-P, WB Host Goat Clonality Polyclonal Isotype IgG Target Name DCUN1D1 Antigen Species Human Immunogen C-RPQIAGTKSTT Conjugation Un-conjugated Alternate Names SCRO; RP42; Defective in cullin neddylation protein 1-like protein 1; Squamous cell carcinoma-related oncogene; DCUN1 domain-containing protein 1; SCCRO; DCN1-like protein 1; DCUN1L1; DCNL1; Tes3 Application Instructions Application table Application Dilution IHC-P 5 - 10 µg/ml WB 0.3 - 1 µg/ml Application Note IHC-P: Antigen Retrieval: Steam tissue section in Citrate buffer (pH 6.0). WB: Recommend incubate at RT for 1h. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 30 kDa Properties Form Liquid Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Buffer Tris saline (pH 7.3), 0.02% Sodium azide and 0.5% BSA Preservative 0.02% Sodium azide Stabilizer 0.5% BSA Concentration 0.5 mg/ml www.arigobio.com 1/2 Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use.
    [Show full text]
  • Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma
    Research Article Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma William M. Lin,1,3,5 Alissa C. Baker,1,3 Rameen Beroukhim,1,3,5 Wendy Winckler,1,3,5 Whei Feng,1,3,5 Jennifer M. Marmion,7 Elisabeth Laine,8 Heidi Greulich,1,3,5 Hsiuyi Tseng,1,3 Casey Gates,5 F. Stephen Hodi,1 Glenn Dranoff,1 William R. Sellers,1,6 Roman K. Thomas,9,10 Matthew Meyerson,1,3,4,5 Todd R. Golub,2,3,5 Reinhard Dummer,8 Meenhard Herlyn,7 Gad Getz,3,5 and Levi A. Garraway1,3,5 Departments of 1Medical Oncology and 2Pediatric Oncology and 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School; 4Department of Pathology, Harvard Medical School, Boston, Massachusetts; 5The Broad Institute of M.I.T. and Harvard; 6Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; 7Cancer Biology Division, Wistar Institute, Philadelphia, Pennsylvania; 8Department of Dermatology, University of Zurich Hospital, Zu¨rich, Switzerland; 9Max Planck Institute for Neurological Research with Klaus Joachim Zulch Laboratories of the Max Planck Society and the Medical Faculty of the University of Cologne; and 10Center for Integrated Oncology and Department I for Internal Medicine, University of Cologne, Cologne, Germany Abstract tumorigenesis have been derived from functional studies involving The classification of human tumors based on molecular cultured human cancer cells (e.g., established cell lines, short-term cultures, etc.). Despite their limitations, cancer cell line collections criteria offers tremendous clinical potential; however, dis- cerning critical and ‘‘druggable’’ effectors on a large scale will whose genetic alterations reflect their primary tumor counterparts also require robust experimental models reflective of tumor should provide malleable proxies that facilitate mechanistic genomic diversity.
    [Show full text]
  • Short Article CAND1 Binds to Unneddylated CUL1 and Regulates
    Molecular Cell, Vol. 10, 1519–1526, December, 2002, Copyright 2002 by Cell Press CAND1 Binds to Unneddylated CUL1 Short Article and Regulates the Formation of SCF Ubiquitin E3 Ligase Complex Jianyu Zheng,1 Xiaoming Yang,1 Despite the importance of cullins in controlling many Jennifer M. Harrell,1 Sophia Ryzhikov,1 essential biological processes, the mechanism that reg- Eun-Hee Shim,1 Karin Lykke-Andersen,2 ulates the cullin-containing ubiquitin E3 ligases remains Ning Wei,2 Hong Sun,1 Ryuji Kobayashi,3 unclear. In SCF, the F box proteins are short-lived pro- and Hui Zhang1,4 teins that undergo CUL1/SKP1-dependent degradation 1Department of Genetics (Wirbelauer et al., 2000; Zhou and Howley, 1998). Dele- Yale University School of Medicine tion of the F box region abolishes the binding of F box 333 Cedar Street proteins to SKP1 and CUL1, and consequently increases 2 Department of Molecular, Cellular, the stability of F box proteins. This substrate-indepen- and Developmental Biology dent proteolysis of F box proteins is likely the result of Yale University autoubiquitination by the ubiquitin E2 and E1 enzymes New Haven, Connecticut 06520 through a CUL1/SKP1-dependent mechanism. 3 Cold Spring Harbor Laboratory The carboxy-terminal ends of cullins are often covalently Cold Spring Harbor, New York 11724 modified by a ubiquitin-like protein, NEDD8/RUB1, and this modification appears to associate with active E3 li- gases (Hochstrasser, 2000). Like ubiquitin modification, Summary neddylation requires E1 (APP-BP1 and UBA3)-activating and E2 (UBC12)-conjugating enzymes (Hochstrasser, The SCF ubiquitin E3 ligase regulates ubiquitin-depen- 2000).
    [Show full text]
  • TXNDC5, a Newly Discovered Disulfide Isomerase with a Key Role in Cell Physiology and Pathology
    Int. J. Mol. Sci. 2014, 15, 23501-23518; doi:10.3390/ijms151223501 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review TXNDC5, a Newly Discovered Disulfide Isomerase with a Key Role in Cell Physiology and Pathology Elena Horna-Terrón 1, Alberto Pradilla-Dieste 1, Cristina Sánchez-de-Diego 1 and Jesús Osada 2,3,* 1 Grado de Biotecnología, Universidad de Zaragoza, Zaragoza E-50013, Spain; E-Mails: [email protected] (E.H.-T.); [email protected] (A.P.-D.); [email protected] (C.S.-D.) 2 Departamento Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón (IIS), Universidad de Zaragoza, Zaragoza E-50013, Spain 3 CIBER de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid E-28029, Spain * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +34-976-761-644; Fax: +34-976-761-612. External Editor: Johannes Haybaeck Received: 16 September 2014; in revised form: 1 December 2014 / Accepted: 5 December 2014 / Published: 17 December 2014 Abstract: Thioredoxin domain-containing 5 (TXNDC5) is a member of the protein disulfide isomerase family, acting as a chaperone of endoplasmic reticulum under not fully characterized conditions As a result, TXNDC5 interacts with many cell proteins, contributing to their proper folding and correct formation of disulfide bonds through its thioredoxin domains. Moreover, it can also work as an electron transfer reaction, recovering the functional isoform of other protein disulfide isomerases, replacing reduced glutathione in its role. Finally, it also acts as a cellular adapter, interacting with the N-terminal domain of adiponectin receptor.
    [Show full text]
  • Identification of Core Genes Involved in the Progression of Cervical
    International Journal of Molecular Sciences Article Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis Marina Dudea-Simon 1, Dan Mihu 1, Alexandru Irimie 2,3, Roxana Cojocneanu 4, Schuyler S. Korban 5, Radu Oprean 6, Cornelia Braicu 4,* and Ioana Berindan-Neagoe 4,7 1 2nd Obstetrics and Gynecology Department, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania; [email protected] (M.D.-S.); [email protected] (D.M.) 2 Department of Surgery, “Prof. Dr. Ion Chiricuta” Oncology Institute, 400015 Cluj-Napoca, Romania; [email protected] 3 Department of Surgical Oncology and Gynecological Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 4 Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 23 Marinescu Street, 400337 Cluj-Napoca, Romania; [email protected] (R.C.); [email protected] (I.B.-N.) 5 Department of Natural and Environmental Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA; [email protected] 6 Analytical Chemistry Department, Iuliu Hatieganu University of Medicine and Pharmacy, 4, Louis Pasteur Street, 400349 Cluj-Napoca, Romania; [email protected] 7 Department of Functional Genomics and Experimental Pathology, “Prof. Dr. Ion Chiricu¸tă” Oncology Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania * Correspondence: [email protected] Received: 5 September 2020; Accepted: 1 October 2020; Published: 3 October 2020 Abstract: In spite of being a preventable disease, cervical cancer (CC) remains at high incidence, and it has a significant mortality rate. Although hijacking of the host cellular pathway is fundamental for developing a better understanding of the human papillomavirus (HPV) pathogenesis, a major obstacle is identifying the central molecular targets involved in HPV-driven CC.
    [Show full text]